Ryuji Tanosaki, MD, PhD1, Yoshiki Okuyama, M.D.2*, Tohru Iseki, MD, PhD3*, Makoto Handa4*, Shuichi Kino, M.D.5*, Katsuya Ikuta, MD, PhD6, Shigehisa Yoshida, M.T.7*, Kyoko Haraguchi, M.D.2*, Naomi Shimizu, MD8*, Shio Sakai, MD, PhD9*, Naohide Watanabe, MD, PhD10*, Tomoe Uemura, M.T.11*, Yoshie Kawahara, M.T.6*, Kazuo Muroi, M.D., Ph.D.12*, Tokiko Nagamura-Inoue, MD, PhD13 and Minoko Takanashi, MD, Ph.D14*
1Department of Blood Transfusion and Cellular Therapy, National Cancer Center Hospital, Tokyo, Japan
2Division of Transfusion and Cell Therapy, Tokyo Metropolitan Komagome Hospital, Tokyo, Japan
3Department of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Chiba, Japan
4Center for Transfusion Medicine & Cell Therapy, Keio University, Tokyo, Japan
5Hokkaido Block Blood Center, Japanese Red Cross Society, Hokkaido, Japan
6Asahikawa Medical University Hospital, Hokkaido, Japan
7National Cancer Center Hospital, Tokyo, Japan
8Department of Blood Transfusion, Toho University Medical Center Sakura Hospital, Chiba, Japan
9Division of Transfusion Medicine and Cell Therapy, Chiba University Hospital, Chiba, Japan
10Department of Transfusion Medicine and Cell Therapy, Keio University School of Medicine, Tokyo, Japan
11Center for Transfusion Medicine and Cell Therapy, Keio University, Tokyo, Japan
12Division of Cell Transplantation and Transfusion, Jichi Medical University, Tochigi, Japan
13Department of Cell Processing and Transfusion, The Institute of Medical Science, University of Tokyo, Tokyo, Japan
14Blood Service Headquarters, Japanese Red Cross, Tokyo, Japan